Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of add on therapies in patients with hypercholesterolemia undergoing statin therapy

Published:2020-08-09 Issue:17 Volume:21 Page:2137-2151
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Tomlinson Brian¹^ORCID,Chan Paul²,Zhang Yuzhen³^ORCID,Lam Christopher Wai Kei¹^ORCID

Affiliation:

1. Faculty of Medicine, Macau University of Science and Technology, Macau, China

2. Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan

3. Research Center for Translational Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1801638

Reference158 articles.

1. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk

2. Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

3. Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

4. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serious Adverse Events of Inclisiran in Patients With Hypercholesterolemia, a Meta-Analysis of ORION Trials;Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine;2023-11-06

2. Current Insights on Dyslipidaemia Management for Prevention of Atherosclerotic Cardiovascular Disease: A Malaysian Perspective;Malaysian Journal of Medical Sciences;2023-02-28

3. Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphoma;Leukemia & Lymphoma;2021-12-31

4. An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease;Expert Opinion on Drug Metabolism & Toxicology;2021-12-02

5. Lipid-Lowering Drug Therapy: Critical Approach for Implementation in Clinical Practice;American Journal of Cardiovascular Drugs;2021-09-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3